TP53 and endometrial carcinoma: We explored the variation and prognostic significance of age, overweight/obesity, and type 2 diabetes in 515 women with endometrial carcinoma that were classified into molecular subgroups by immunohistochemistry of MMR proteins and p53, as well as POLE sequencing.